Ventura Corporation (San Juan, P.R)
ēsika 3-in-1 Pro Make Up Foundation SPF 20
FULL PRESCRIBING INFORMATION: CONTENTS*
FULL PRESCRIBING INFORMATION
Drug Facts
Active Ingredients
Octinoxate (7%), Oxybenzone (2%), Titanium Dioxide (2%)
Purpose
Sunscreen
ESIKA Uses
- helps prevent sunburn
- higher SPF gives more sunburn protection
- provides moderate protection against sunburn
Warnings
- When using this product keep out of eyes. Rinse with water to remove.
- Stop use and ask a doctor if rash and irritation develops and lasts.
-
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- apply smootly every morning before sun exposure and as needed.
- apply evenly on face and neck using a latex pad. Touch up when necessary.
- moderate sun protection product.
ESIKA Other information
- Sun alert: Limiting sun exposure, wearing protective clothing, and using sunscreens may reduce the risk of skin aging, skin cancer, and other harmful effects of the sun.
Inactive ingredients
Isostearyl neopentanoate, C12-15 alkyl benzoate, polymethyl methacrylate, corn starch, silica, mica, ethylhexyl palmitate, ozokerite, copernicia cerifera cera (copernicia cerifera (carnauba) wax), phenoxyethanol, octyldodecanol, trimethylsiloxysilicate, dimethicone, methylparaben, tocopheryl acetate, microcrystalline wax, propylparaben, petrolatum, phospholipids, bht, c9-13 fluoroalcohol, butylparaben, ethylparaben, phosphoric acid, cholesterol, isobutylparaben, candelilla cera (euphorbia cerifera (candelilla) wax), cera alba (beeswax), cetearyl alcohol, cetearyl glucoside, polyglyceryl-2 dipolyhydroxystearate, glycosphingolipids, chitosan, ci 77492 (iron oxides), ci 77491 (iron oxides), ci 77499 (iron oxides).
PRINCIPAL DISPLAY PANEL - 6 g Carton - Beige 1
ēsika
3-in-1 Pro Make Up
Foundation SPF 20
6 g e (.21 oz.)
PRINCIPAL DISPLAY PANEL - 6 g Carton - Beige 2
ēsika
3-in-1 Pro Make Up
Foundation SPF 20
6 g e (.21 oz.)
PRINCIPAL DISPLAY PANEL - 6 g Carton - Beige 3
ēsika
3-in-1 Pro Make Up
Foundation SPF 20
6 g e (.21 oz.)
PRINCIPAL DISPLAY PANEL - 6 g Carton - Beige 4
ēsika
3-in-1 Pro Make Up
Foundation SPF 20
6 g e (.21 oz.)
PRINCIPAL DISPLAY PANEL - 6 g Carton - Beige 5
ēsika
3-in-1 Pro Make Up
Foundation SPF 20
6 g e (.21 oz.)
PRINCIPAL DISPLAY PANEL - 6 g Carton - Beige 6
ēsika
3-in-1 Pro Make Up
Foundation SPF 20
6 g e (.21 oz.)
PRINCIPAL DISPLAY PANEL - 6 g Carton - Rosa 1
ēsika
3-in-1 Pro Make Up
Foundation SPF 20
6 g e (.21 oz.)
PRINCIPAL DISPLAY PANEL - 6 g Carton - Rosa 2
ēsika
3-in-1 Pro Make Up
Foundation SPF 20
6 g e (.21 oz.)
PRINCIPAL DISPLAY PANEL - 6 g Carton - Rosa 3
ēsika
3-in-1 Pro Make Up
Foundation SPF 20
6 g e (.21 oz.)
PRINCIPAL DISPLAY PANEL - 6 g Carton - Rosa 4
ēsika
3-in-1 Pro Make Up
Foundation SPF 20
6 g e (.21 oz.)
PRINCIPAL DISPLAY PANEL - 6 g Carton - Rosa 5
ēsika
3-in-1 Pro Make Up
Foundation SPF 20
6 g e (.21 oz.)
PRINCIPAL DISPLAY PANEL - 6 g Carton - Rosa 6
ēsika
3-in-1 Pro Make Up
Foundation SPF 20
6 g e (.21 oz.)
ESIKA
Octinoxate, Oxybenzone, and Titanium Dioxide POWDER
Product Information
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13537-329 |
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Product Characteristics
|
Color
|
BROWN (Beige 1) |
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:13537-329-01 |
6 in 1 CASE |
|
|
2 |
NDC:13537-329-02 |
1 in 1 BOX |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
part |
part352 |
2011-05-17 |
|
|
ESIKA
Octinoxate, Oxybenzone, and Titanium Dioxide POWDER
Product Information
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13537-330 |
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Product Characteristics
|
Color
|
BROWN (Beige 2) |
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:13537-330-01 |
6 in 1 CASE |
|
|
2 |
NDC:13537-330-02 |
1 in 1 BOX |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
part |
part352 |
2011-05-17 |
|
|
ESIKA
Octinoxate, Oxybenzone, and Titanium Dioxide POWDER
Product Information
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13537-331 |
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Product Characteristics
|
Color
|
BROWN (Beige 3) |
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:13537-331-01 |
6 in 1 CASE |
|
|
2 |
NDC:13537-331-02 |
1 in 1 BOX |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
part |
part352 |
2011-05-17 |
|
|
ESIKA
Octinoxate, Oxybenzone, and Titanium Dioxide POWDER
Product Information
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13537-332 |
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Product Characteristics
|
Color
|
BROWN (Beige 4) |
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:13537-332-01 |
6 in 1 CASE |
|
|
2 |
NDC:13537-332-02 |
1 in 1 BOX |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
part |
part352 |
2011-05-17 |
|
|
ESIKA
Octinoxate, Oxybenzone, and Titanium Dioxide POWDER
Product Information
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13537-333 |
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Product Characteristics
|
Color
|
BROWN (Beige 5) |
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:13537-333-01 |
6 in 1 CASE |
|
|
2 |
NDC:13537-333-02 |
1 in 1 BOX |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
part |
part352 |
2011-05-17 |
|
|
ESIKA
Octinoxate, Oxybenzone, and Titanium Dioxide POWDER
Product Information
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13537-334 |
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Product Characteristics
|
Color
|
BROWN (Beige 6) |
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:13537-334-01 |
6 in 1 CASE |
|
|
2 |
NDC:13537-334-02 |
1 in 1 BOX |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
part |
part352 |
2011-05-17 |
|
|
ESIKA
Octinoxate, Oxybenzone, and Titanium Dioxide POWDER
Product Information
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13537-335 |
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Product Characteristics
|
Color
|
RED (Rosa 1) |
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:13537-335-01 |
6 in 1 CASE |
|
|
2 |
NDC:13537-335-02 |
1 in 1 BOX |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
part |
part352 |
2011-05-17 |
|
|
ESIKA
Octinoxate, Oxybenzone, and Titanium Dioxide POWDER
Product Information
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13537-336 |
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Product Characteristics
|
Color
|
RED (Rosa 2) |
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:13537-336-01 |
6 in 1 CASE |
|
|
2 |
NDC:13537-336-02 |
1 in 1 BOX |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
part |
part352 |
2011-05-17 |
|
|
ESIKA
Octinoxate, Oxybenzone, and Titanium Dioxide POWDER
Product Information
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13537-337 |
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Product Characteristics
|
Color
|
RED (Rosa 3) |
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:13537-337-01 |
6 in 1 CASE |
|
|
2 |
NDC:13537-337-02 |
1 in 1 BOX |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
part |
part352 |
2011-05-17 |
|
|
ESIKA
Octinoxate, Oxybenzone, and Titanium Dioxide POWDER
Product Information
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13537-338 |
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Product Characteristics
|
Color
|
RED (Rosa 4) |
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:13537-338-01 |
6 in 1 CASE |
|
|
2 |
NDC:13537-338-02 |
1 in 1 BOX |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
part |
part352 |
2011-05-17 |
|
|
ESIKA
Octinoxate, Oxybenzone, and Titanium Dioxide POWDER
Product Information
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13537-339 |
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Product Characteristics
|
Color
|
RED (Rosa 5) |
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:13537-339-01 |
6 in 1 CASE |
|
|
2 |
NDC:13537-339-02 |
1 in 1 BOX |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
part |
part352 |
2011-05-17 |
|
|
ESIKA
Octinoxate, Oxybenzone, and Titanium Dioxide POWDER
Product Information
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13537-340 |
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Product Characteristics
|
Color
|
RED (Rosa 6) |
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:13537-340-01 |
6 in 1 CASE |
|
|
2 |
NDC:13537-340-02 |
1 in 1 BOX |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
part |
part352 |
2011-05-17 |
|
|